loading...| Preferred Name |
Lapatinib |
|
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00026229 |
|
| Database_Cross_Reference |
NDFRT:N0000176088 DRUGBANK:DB01259 USPMG:MTHU002524 MMSL:d06672 MSH:C490728 SNOMEDCT_US:425466009 VANDF:4026029 NCI_NCI-GLOSS:CDR0000390335 MEDCIN:303542 RXNORM:480167 NDDF:012022 ATC:L01XE07 NDFRT:N0000179782 SNOMEDCT_US:425820005 PDQ:CDR0000269659 NCI:C26653 MTHSPL:0VUA21238F NCI_FDA:0VUA21238F |
|
| label |
Lapatinib |
|
| MCID |
MC00522020 |
|
| PMOID |
PMO:00026229 |
|
| prefixIRI |
pmo:PMO_00026229 |
|
| prefLabel |
Lapatinib |
|
| Synonym |
N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine Tycerb Lapatinib (substance) LAPATINIB lapatinib lapatinib [Chemical/Ingredient] Lapatinib tosilate hydrate Lapatinib (product) N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine lapatinib (medication) FMM |
|
| Tree Number |
T6.4.4.1.2.27.21 |
|
| subClassOf |